Due to the Texas cold snap, many investors have shied away from GEVO stock. But even without this tragic storm, the underlying biofuel specialist has another headwind to contend with. More
Anticipation of Better Vaccine News Could Drive Ocugen Higher
From a December low of 29 cents, OCGN stock now trades at about $11, a return of over 3600%. Not bad for a name that was nearly delisted. More
Play a Game of ‘Pot Monopoly’ with Tilray Stock
After the merger with Aphria is finalized, TLRY stock holders will own a small piece of the biggest cannabis company on the planet. More
Sundial Growers Is Likely to Fall Further Given Its Huge Dilution
Sundial Growers is likely to fall further given its huge dilution. Wait to buy SNDL stock until it falls to 46 cents per share or 62.7% below today's price. More
VRTV Stock: Why Little-Known Veritiv Is Rocketing Higher
The earnings investors in VRTV stock saw today absolutely blew away expectations, and this stock looks like it has lots of momentum right now. More
Bumble Is an Interesting Recovery Trade for the Adventurous
It's not exactly a "vaccine stock," but Bumble stock should reward long-term shareholders as the world reopens and people make connections. More
The Selloff in Fastly Stock Is a Gift Dip To Buy
Fastly has plenty of long-term opportunities, even if the stock price doesn't reflect it right now. Let's dig deeper on FSLY stock. More
